These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
727 related items for PubMed ID: 18783534
1. The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. Kingsberg SA, Simon JA, Goldstein I. J Sex Med; 2008 Sep 02; 5 Suppl 4():182-93; quiz 193. PubMed ID: 18783534 [Abstract] [Full Text] [Related]
2. Editorial comments on "the current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women". Goldstein I. J Sex Med; 2008 Sep 02; 5 Suppl 4():177-8. PubMed ID: 18783531 [No Abstract] [Full Text] [Related]
3. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder. Kingsberg S, Shifren J, Wekselman K, Rodenberg C, Koochaki P, Derogatis L. J Sex Med; 2007 Jul 02; 4(4 Pt 1):1001-8. PubMed ID: 17627745 [Abstract] [Full Text] [Related]
4. Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. Davis SR, Braunstein GD. J Sex Med; 2012 Apr 02; 9(4):1134-48. PubMed ID: 22304681 [Abstract] [Full Text] [Related]
5. Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women. Kingsberg S. J Sex Med; 2007 Mar 02; 4 Suppl 3():227-34. PubMed ID: 17394595 [Abstract] [Full Text] [Related]
6. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. Krapf JM, Simon JA. Maturitas; 2009 Jul 20; 63(3):213-9. PubMed ID: 19487090 [Abstract] [Full Text] [Related]
7. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Leiblum SR, Koochaki PE, Rodenberg CA, Barton IP, Rosen RC. Menopause; 2006 Jul 20; 13(1):46-56. PubMed ID: 16607098 [Abstract] [Full Text] [Related]
8. Satisfying sexual events as outcome measures in clinical trial of female sexual dysfunction. Kingsberg SA, Althof SE. J Sex Med; 2011 Dec 20; 8(12):3262-70. PubMed ID: 21883949 [Abstract] [Full Text] [Related]
9. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S, Waldbaum A, Bouchard C, Derzko C, Buch A, Rodenberg C, Lucas J, Davis S. J Clin Endocrinol Metab; 2005 Sep 20; 90(9):5226-33. PubMed ID: 16014407 [Abstract] [Full Text] [Related]
10. Hypoactive sexual desire disorder in menopausal women: a survey of Western European women. Dennerstein L, Koochaki P, Barton I, Graziottin A. J Sex Med; 2006 Mar 20; 3(2):212-22. PubMed ID: 16490014 [Abstract] [Full Text] [Related]
11. Role of testosterone in the treatment of hypoactive sexual desire disorder. Schwenkhagen A, Studd J. Maturitas; 2009 Jun 20; 63(2):152-9. PubMed ID: 19359109 [Abstract] [Full Text] [Related]
12. Clinically relevant changes in sexual desire, satisfying sexual activity and personal distress as measured by the profile of female sexual function, sexual activity log, and personal distress scale in postmenopausal women with hypoactive sexual desire disorder. DeRogatis LR, Graziottin A, Bitzer J, Schmitt S, Koochaki PE, Rodenberg C. J Sex Med; 2009 Jan 20; 6(1):175-83. PubMed ID: 19170847 [Abstract] [Full Text] [Related]
13. Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women. Rosen RC, Maserejian NN, Connor MK, Krychman ML, Brown CS, Goldstein I. Menopause; 2012 Apr 20; 19(4):396-405. PubMed ID: 22076307 [Abstract] [Full Text] [Related]
14. Approved hormonal treatments for HSDD: an unmet medical need. Snabes MC, Simes SM. J Sex Med; 2009 Jul 20; 6(7):1846-9. PubMed ID: 19453872 [Abstract] [Full Text] [Related]
15. Menopause and sexual desire: the role of testosterone. Nappi RE, Albani F, Santamaria V, Tonani S, Martini E, Terreno E, Brambilla E, Polatti F. Menopause Int; 2010 Dec 20; 16(4):162-8. PubMed ID: 21156854 [Abstract] [Full Text] [Related]
16. Testosterone therapy in women: a review. Bolour S, Braunstein G. Int J Impot Res; 2005 Dec 20; 17(5):399-408. PubMed ID: 15889125 [Abstract] [Full Text] [Related]
17. Testosterone therapy for sexual dysfunction in postmenopausal women. Hubayter Z, Simon JA. Climacteric; 2008 Jun 20; 11(3):181-91. PubMed ID: 18568783 [Abstract] [Full Text] [Related]
18. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. Parish SJ, Simon JA, Davis SR, Giraldi A, Goldstein I, Goldstein SW, Kim NN, Kingsberg SA, Morgentaler A, Nappi RE, Park K, Stuenkel CA, Traish AM, Vignozzi L. J Sex Med; 2021 May 20; 18(5):849-867. PubMed ID: 33814355 [Abstract] [Full Text] [Related]
19. A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder. White WB, Grady D, Giudice LC, Berry SM, Zborowski J, Snabes MC. Am Heart J; 2012 Jan 20; 163(1):27-32. PubMed ID: 22172433 [Abstract] [Full Text] [Related]
20. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Davis SR, van der Mooren MJ, van Lunsen RH, Lopes P, Ribot C, Rees M, Moufarege A, Rodenberg C, Buch A, Purdie DW. Menopause; 2006 Jan 20; 13(3):387-96. PubMed ID: 16735935 [Abstract] [Full Text] [Related] Page: [Next] [New Search]